CHI Advisors as of March 31, 2021
Portfolio Holdings for CHI Advisors
CHI Advisors holds 21 positions in its portfolio as reported in the March 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Cullinan Oncology (CGEM) | 18.4 | $92M | 2.2M | 41.67 | |
| Pliant Therapeutics (PLRX) | 18.3 | $91M | 2.3M | 39.33 | |
| Repare Therapeutics Ord (RPTX) | 15.7 | $79M | 2.6M | 30.69 | |
| Prometheus Biosciences | 10.5 | $53M | 2.9M | 18.26 | |
| Orchard Therapeutics Ads | 5.9 | $29M | 4.1M | 7.26 | |
| Oncorus | 4.9 | $25M | 1.8M | 13.92 | |
| Keros Therapeutics (KROS) | 4.9 | $25M | 401k | 61.55 | |
| Ikena Oncology (IKNA) | 4.6 | $23M | 815k | 28.25 | |
| Larimar Therapeutics (LRMR) | 4.4 | $22M | 1.5M | 14.61 | |
| Inozyme Pharma (INZY) | 3.7 | $18M | 927k | 19.80 | |
| Freeline Therapeutics Hldgs Sponsored Ads | 3.4 | $17M | 1.4M | 12.30 | |
| Akouos | 2.4 | $12M | 858k | 13.87 | |
| Precision Biosciences Ord | 1.4 | $7.2M | 692k | 10.35 | |
| Corvus Pharmaceuticals (CRVS) | 0.4 | $2.1M | 679k | 3.08 | |
| G1 Therapeutics | 0.2 | $1.2M | 50k | 24.06 | |
| Kezar Life Sciences | 0.2 | $1.0M | 174k | 5.96 | |
| Ovid Therapeutics (OVID) | 0.2 | $995k | 248k | 4.02 | |
| Global Blood Therapeutics In | 0.1 | $611k | 15k | 40.73 | |
| Adverum Biotechnologies | 0.1 | $396k | 40k | 9.85 | |
| Blueprint Medicines (BPMC) | 0.1 | $340k | 3.5k | 97.14 | |
| Ultragenyx Pharmaceutical (RARE) | 0.0 | $228k | 2.0k | 114.00 |
